|
ZNF785 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.98114999999666E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.121340E-03 |
| Normal-vs-Stage2 |
8.567600E-02 |
| Normal-vs-Stage3 |
8.660000E-02 |
| Normal-vs-Stage4 |
1.213970E-01 |
| Stage1-vs-Stage2 |
7.188000E-01 |
| Stage1-vs-Stage3 |
8.249800E-01 |
| Stage1-vs-Stage4 |
6.461200E-01 |
| Stage2-vs-Stage3 |
6.889000E-01 |
| Stage2-vs-Stage4 |
8.991000E-01 |
| Stage3-vs-Stage4 |
6.203800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.44669999996494E-06 |
| Normal-vs-AfricanAmerican |
2.193500E-02 |
| Normal-vs-Asian |
6.449400E-01 |
| Caucasian-vs-AfricanAmerican |
1.926360E-01 |
| Caucasian-vs-Asian |
3.804400E-01 |
| AfricanAmerican-vs-Asian |
6.720000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.74420000000386E-05 |
| Normal-vs-Female |
2.220200E-04 |
| Male-vs-Female |
4.686800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.399770E-01 |
| Normal-vs-Extreme_Weight |
8.743100E-03 |
| Normal-vs-Obese |
4.233700E-04 |
| Normal-vs-Extreme_Obese |
2.060800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.344000E-01 |
| Normal_Weight-vs-Obese |
3.973700E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.209000E-01 |
| Extreme_Weight-vs-Obese |
1.147180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.730800E-01 |
| Obese-vs-Extreme_Obese |
9.916200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.555600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.90519999998529E-06 |
| Normal-vs-Age(61-80Yrs) |
1.183490E-03 |
| Normal-vs-Age(81-100Yrs) |
7.081200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.547200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.858000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.881600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.425900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.098400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.974200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.12010000000262E-07 |
| Normal-VS-Type2 PRCC |
6.364400E-01 |
| Normal-VS-KIRP CIMP |
5.238300E-02 |
| Normal-VS-Unclassified PRCC |
3.764400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.77846999999121E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.792400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.616600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.520600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.579100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.398200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.389200E-01 |
| Normal-vs-N1 |
2.852400E-02 |
| Normal-vs-N2 |
6.831000E-01 |
| N0-vs-N1 |
1.121020E-01 |
| N0-vs-N2 |
9.075800E-01 |
| N1-vs-N2 |
4.712600E-01 |
|
|
